Repurposing of Drug Aspirin in Colon Cancer: Therapeutic Approach

  • Neve V
  • Kamble A
  • Karwa P
N/ACitations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Drug repurposing, exploring new uses for existing drugs, offers significant advantages over developing new ones. Repurposed drugs have already undergone safety testing, reducing failure chances. Pre-existing data and manufacturing knowledge shorten the process. Development is cheaper, with estimates at $300 million compared to $2-3 billion for new drugs. Repurposed drugs can reach the market in 3-12 years, versus 10-17 years for new drugs. Overall, drug repurposing is a promising approach for fa

Cite

CITATION STYLE

APA

Neve, V., Kamble, A., & Karwa, P. (2024). Repurposing of Drug Aspirin in Colon Cancer: Therapeutic Approach. Clinical Cancer Investigation Journal, 13(1), 23–28. https://doi.org/10.51847/brevhxsqb9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free